Chevreau C - Search Results

1

Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients With Nonmetastatic Muscle-Invasive Bladder Cancer: Results of the GETUG-AFU V05 VESPER Trial.

Pfister C, Gravis G, Fléchon A, Chevreau C, Mahammedi H, Laguerre B, Guillot A, Joly F, Soulié M, Allory Y, Harter V, Culine S; VESPER Trial Investigators. Pfister C, et al. Among authors: chevreau c. J Clin Oncol. 2022 Jun 20;40(18):2013-2022. doi: 10.1200/JCO.21.02051. Epub 2022 Mar 7. J Clin Oncol. 2022. PMID: 35254888 Clinical Trial.

2

High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series.

Blay JY, Conroy T, Chevreau C, Thyss A, Quesnel N, Eghbali H, Bouabdallah R, Coiffier B, Wagner JP, Le Mevel A, Dramais-Marcel D, Baumelou E, Chauvin F, Biron P. Blay JY, et al. Among authors: chevreau c. J Clin Oncol. 1998 Mar;16(3):864-71. doi: 10.1200/JCO.1998.16.3.864. J Clin Oncol. 1998. PMID: 9508167

3

Subcutaneous interleukin-2, interferon alfa-2a, and continuous infusion of fluorouracil in metastatic renal cell carcinoma: a multicenter phase II trial. Groupe Français d'Immunothérapie.

Ravaud A, Audhuy B, Gomez F, Escudier B, Lesimple T, Chevreau C, Douillard JY, Caty A, Geoffrois L, Ferrero JM, Linassier C, Drevon M, Négrier S. Ravaud A, et al. Among authors: chevreau c. J Clin Oncol. 1998 Aug;16(8):2728-32. doi: 10.1200/JCO.1998.16.8.2728. J Clin Oncol. 1998. PMID: 9704724 Clinical Trial.

4

Phase I-II trial of intensification of the MAID regimen with support of lenograstim (rHuG-CSF) in patients with advanced soft-tissue sarcoma (STS).

Chevreau C, Bui BN, Chevallier B, Krakowski I, Maugard C, Mihura J, Coindre JM, Gil B, Cour-Chabernaud V. Chevreau C, et al. Am J Clin Oncol. 1999 Jun;22(3):267-72. doi: 10.1097/00000421-199906000-00011. Am J Clin Oncol. 1999. PMID: 10362334 Clinical Trial.

5

Second non-germ cell malignancies in patients treated for stage I-II testicular seminoma.

Bachaud JM, Berthier F, Soulié M, Malavaud B, Plante P, Rischmann P, Chevreau C, Daly-Schveitzer N, Grosclaude P. Bachaud JM, et al. Among authors: chevreau c. Radiother Oncol. 1999 Feb;50(2):191-7. doi: 10.1016/s0167-8140(98)00101-7. Radiother Oncol. 1999. PMID: 10368043

6

Risk model for severe anemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens. The Elypse 1 Study Group.

Ray-Coquard I, Le Cesne A, Rubio MT, Mermet J, Maugard C, Ravaud A, Chevreau C, Sebban C, Bachelot T, Biron P, Blay JY. Ray-Coquard I, et al. Among authors: chevreau c. J Clin Oncol. 1999 Sep;17(9):2840-6. doi: 10.1200/JCO.1999.17.9.2840. J Clin Oncol. 1999. PMID: 10561360

7

Doxorubicin and ifosfamide in patients with metastatic sarcomatoid renal cell carcinoma: a phase II study of the Genitourinary Group of the French Federation of Cancer Centers.

Escudier B, Droz JP, Rolland F, Terrier-Lacombe MJ, Gravis G, Beuzeboc P, Chauvet B, Chevreau C, Eymard JC, Lesimple T, Merrouche Y, Oudard S, Priou F, Guillemare C, Gourgou S, Culine S; Genitourinary Group of the French Federation of Cancer Centers. Escudier B, et al. Among authors: chevreau c. J Urol. 2002 Sep;168(3):959-61. doi: 10.1016/S0022-5347(05)64551-X. J Urol. 2002. PMID: 12187199 Clinical Trial.

8

A phase II study of irinotecan in patients with advanced renal cell carcinoma.

Fizazi K, Rolland F, Chevreau C, Droz JP, Mery-Mignard D, Culine S, Escudier B. Fizazi K, et al. Among authors: chevreau c. Cancer. 2003 Jul 1;98(1):61-5. doi: 10.1002/cncr.11474. Cancer. 2003. PMID: 12833456 Free article. Clinical Trial.

9

Renal angiomyolipoma associated with rapid enlargement [correction of enlargment] and inferior vena caval tumor thrombus.

Gamé X, Soulié M, Moussouni S, Roux D, Escourrou G, Chevreau C, Aziza R. Gamé X, et al. Among authors: chevreau c. J Urol. 2003 Sep;170(3):918-9. doi: 10.1097/01.ju.0000074709.64318.5c. J Urol. 2003. PMID: 12913732 No abstract available.

10

Long-term efficacy of two cycles of BEP regimen in high-risk stage I nonseminomatous testicular germ cell tumors with embryonal carcinoma and/or vascular invasion.

Chevreau C, Mazerolles C, Soulié M, Gaspard MH, Mourey L, Bujan L, Plante P, Rischmann P, Bachaud JM, Malavaud B. Chevreau C, et al. Eur Urol. 2004 Aug;46(2):209-14; discussion 214-5. doi: 10.1016/j.eururo.2004.03.022. Eur Urol. 2004. PMID: 15245815 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

314 results

Search Page